arrow
A

Antonio Sánchez

Hospital Universitario Fundación Jiménez Díaz
H指数:33
被引数:3,571

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Documento de consenso sobre técnicas neurosonológicas en cefaleas

关于神经声学技术在头痛中的技术共识文件

2024-11-290
OAAI
Association of Complement Factors With Disability Progression in Primary Progressive Multiple Sclerosis
2024-07-011
OAAI
Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study

多发性硬化症患者在疾病改善疗法下的SARS-CoV-2血清阳性率: 一项多中心研究

2023-11-230
OAAI
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis

血清生物标志物水平预测原发性进行性多发性硬化患者的残疾进展

2023-11-086
PRE
Exploring the potential relationship between collagen cross-linking and impaired myocardial relaxation in Marfan syndrome: An observational study using serum biomarkers
2022-04-012
PRE
CSF Chitinase 3-Like 2 Is Associated With Long-term Disability Progression in Patients With Progressive Multiple Sclerosis
2021-11-0117
OAAI
Renal function and clinical outcome of patients with cancer-associated venous thromboembolism randomized to receive apixaban or dalteparin. Results from the Caravaggio trial

随机接受阿哌沙班或达肝素治疗的癌症相关静脉血栓栓塞患者的肾功能和临床结局。卡拉瓦乔试验的结果

2021-08-1217
OAAI
Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma
2021-01-2130
OAAI
Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course
2018-09-1426
OAAI
Immunophenotype and Transcriptome Profile of Patients With Multiple Sclerosis Treated With Fingolimod: Setting Up a Model for Prediction of Response in a 2-Year Translational Study

用芬戈莫德治疗的多发性硬化症患者的免疫表型和转录组概况: 在一项为期2年的转化研究中建立预测反应的模型

2018-07-2533
OAAI